Trial intelligence / Profile preview

Simvastatin as an Add-on Treatment to Copaxone for Relapsing Multiple Sclerosis

NCT00429442Phase 3Withdrawn

Sponsor
Anna Tsakiri
Start
Mar 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of simvastatin in relapsing-remitting multiple sclerosis (RRMS), sponsored by Anna Tsakiri. Planned start Mar 2008; status: withdrawn.

02

Drugs

simvastatin
03

Conditions

relapsing-remitting multiple sclerosis (RRMS)

Beyond the preview

Go deeper on NCT00429442.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00429442.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call